Kiniksa Pharmaceuticals International annual revenue
2021
2022
2023
2024
2025
Kiniksa Pharmaceuticals International Revenue Growth & History (KNSA)
Kiniksa Pharmaceuticals International reported $677.6M in revenue for fiscal 2025, an increase of 60.09% from the previous fiscal year.
View full Kiniksa Pharmaceuticals International company overviewKiniksa Pharmaceuticals International annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $677.6M | $254.3M | +60.09% |
| 2024 | 2024-12-31 | $423.2M | $153.0M | +56.60% |
| 2023 | 2023-12-31 | $270.3M | $50.1M | +22.74% |
| 2022 | 2022-12-31 | $220.2M | $181.6M | +471.24% |
| 2021 | 2021-12-31 | $38.5M | — | — |
Kiniksa Pharmaceuticals International quarterly revenue
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $243.6M | $86.8M | +55.36% |
| Q1 2026 | 2026-03-31 | $214.3M | $76.5M | +55.51% |
| Q4 2025 | 2025-12-31 | $202.1M | $79.6M | +64.95% |
| Q3 2025 | 2025-09-30 | $180.9M | $68.6M | +61.17% |
| Q2 2025 | 2025-06-30 | $156.8M | $48.2M | +44.34% |
| Q1 2025 | 2025-03-31 | $137.8M | $57.9M | +72.54% |
| Q4 2024 | 2024-12-31 | $122.5M | $39.1M | +46.93% |
| Q3 2024 | 2024-09-30 | $112.2M | $45.2M | +67.37% |
| Q2 2024 | 2024-06-30 | $108.6M | $37.2M | +51.99% |
| Q1 2024 | 2024-03-31 | $79.9M | $31.5M | +65.18% |
| Q4 2023 | 2023-12-31 | $83.4M | $21.5M | +34.76% |
| Q3 2023 | 2023-09-30 | $67.0M | −$32.1M | −32.37% |
| Q2 2023 | 2023-06-30 | $71.5M | $44.5M | +164.99% |
| Q1 2023 | 2023-03-31 | $48.3M | $16.2M | +50.19% |
| Q4 2022 | 2022-12-31 | $61.9M | — | — |
| Q3 2022 | 2022-09-30 | $99.1M | $87.0M | +719.64% |
| Q2 2022 | 2022-06-30 | $27.0M | $19.3M | +250.10% |
| Q1 2022 | 2022-03-31 | $32.2M | — | — |
| Q3 2021 | 2021-09-30 | $12.1M | — | — |
| Q2 2021 | 2021-06-30 | $7.7M | — | — |
Kiniksa Pharmaceuticals International revenue growth trends
Kiniksa Pharmaceuticals International's latest reported quarter, Q2 2026, generated $243.6M in revenue, an increase of 55.36% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Kiniksa Pharmaceuticals International source filings ↗